These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 15763453

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Efficacy and safety of budesonide/formoterol single inhaler therapy versus a higher dose of budesonide in moderate to severe asthma.
    Scicchitano R, Aalbers R, Ukena D, Manjra A, Fouquert L, Centanni S, Boulet LP, Naya IP, Hultquist C.
    Curr Med Res Opin; 2004 Sep; 20(9):1403-18. PubMed ID: 15383189
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Efficacy and safety of high-dose budesonide/formoterol (Symbicort) compared with budesonide administered either concomitantly with formoterol or alone in patients with persistent symptomatic asthma.
    Jenkins C, Kolarikova R, Kuna P, Caillaud D, Sanchis J, Popp W, Pettersson E.
    Respirology; 2006 May; 11(3):276-86. PubMed ID: 16635085
    [Abstract] [Full Text] [Related]

  • 6. Effect of budesonide in combination with formoterol for reliever therapy in asthma exacerbations: a randomised controlled, double-blind study.
    Rabe KF, Atienza T, Magyar P, Larsson P, Jorup C, Lalloo UG.
    Lancet; 2006 Aug 26; 368(9537):744-53. PubMed ID: 16935685
    [Abstract] [Full Text] [Related]

  • 7. Efficacy, tolerability, and effect on asthma-related quality of life of formoterol bid via multidose dry powder inhaler and albuterol QID via metered dose inhaler in patients with persistent asthma: a multicenter, randomized, double-blind, double-dummy, placebo-controlled, parallel-group study.
    Busse W, Levine B, Andriano K, Lavecchia C, Yegen U.
    Clin Ther; 2004 Oct 26; 26(10):1587-98. PubMed ID: 15598475
    [Abstract] [Full Text] [Related]

  • 8. A randomized, comparative study of formoterol and terbutaline dry powder inhalers in the treatment of mild to moderate asthma exacerbations in the pediatric acute care setting.
    Bussamra MH, Stelmach R, Rodrigues JC, Cukier A.
    Ann Allergy Asthma Immunol; 2009 Sep 26; 103(3):248-53. PubMed ID: 19788023
    [Abstract] [Full Text] [Related]

  • 9. Tolerability to high doses of formoterol and terbutaline via Turbuhaler for 3 days in stable asthmatic patients.
    Tötterman KJ, Huhti L, Sutinen E, Backman R, Pietinalho A, Falck M, Larsson P, Selroos O.
    Eur Respir J; 1998 Sep 26; 12(3):573-9. PubMed ID: 9762782
    [Abstract] [Full Text] [Related]

  • 10. Double-blind, double-dummy, multinational, multicenter, parallel-group design clinical trial of clinical non-inferiority of formoterol 12 microg/unit dose in a b.i.d. regimen administered via an HFA-propellant-pMDI or a dry powder inhaler in a 12-week treatment period of moderate to severe stable persistent asthma in adult patients.
    Dusser D, Vicaut E, Lefrançois G, Formoterol HFA group.
    Respiration; 2005 Sep 26; 72 Suppl 1():20-7. PubMed ID: 15915009
    [Abstract] [Full Text] [Related]

  • 11. Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group.
    Pauwels RA, Löfdahl CG, Postma DS, Tattersfield AE, O'Byrne P, Barnes PJ, Ullman A.
    N Engl J Med; 1997 Nov 13; 337(20):1405-11. PubMed ID: 9358137
    [Abstract] [Full Text] [Related]

  • 12. The use of inhaled formoterol in the treatment of asthma.
    Berger WE.
    Ann Allergy Asthma Immunol; 2006 Jul 13; 97(1):24-33. PubMed ID: 16892777
    [Abstract] [Full Text] [Related]

  • 13. The CONCEPT trial: a 1-year, multicenter, randomized,double-blind, double-dummy comparison of a stable dosing regimen of salmeterol/fluticasone propionate with an adjustable maintenance dosing regimen of formoterol/budesonide in adults with persistent asthma.
    FitzGerald JM, Boulet LP, Follows RM.
    Clin Ther; 2005 Apr 13; 27(4):393-406. PubMed ID: 15922813
    [Abstract] [Full Text] [Related]

  • 14. Assessment of a relative therapeutic index between inhaled formoterol and salbuterol in asthma patients.
    Rosenborg J, Larsson P, Rott Z, Böcskei C, Poczi M, Juhász G.
    Eur J Clin Pharmacol; 2002 Jul 13; 58(4):S61-7. PubMed ID: 12214580
    [Abstract] [Full Text] [Related]

  • 15. Efficacy and safety of formoterol delivered via a new multidose dry powder inhaler (Certihaler) in adolescents and adults with persistent asthma.
    LaForce C, Prenner BM, Andriano K, Lavecchia C, Yegen U.
    J Asthma; 2005 Mar 13; 42(2):101-6. PubMed ID: 15871441
    [Abstract] [Full Text] [Related]

  • 16. The effect of budesonide and formoterol in one pressurized metered-dose inhaler on patient-reported outcomes in adults with mild-to-moderate persistent asthma.
    Murphy K, Nelson H, Parasuraman B, Boggs R, Miller C, O'Dowd L.
    Curr Med Res Opin; 2008 Mar 13; 24(3):879-94. PubMed ID: 18267051
    [Abstract] [Full Text] [Related]

  • 17. Budesonide/formoterol in a single inhaler versus inhaled corticosteroids alone in the treatment of asthma.
    Tal A, Simon G, Vermeulen JH, Petru V, Cobos N, Everard ML, de Boeck K.
    Pediatr Pulmonol; 2002 Nov 13; 34(5):342-50. PubMed ID: 12357478
    [Abstract] [Full Text] [Related]

  • 18. A real-life cost-effectiveness evaluation of budesonide/formoterol maintenance and reliever therapy in asthma.
    Ställberg B, Ekström T, Neij F, Olsson P, Skoogh BE, Wennergren G, Löfdahl CG, SHARE trial group.
    Respir Med; 2008 Oct 13; 102(10):1360-70. PubMed ID: 18723335
    [Abstract] [Full Text] [Related]

  • 19. Comparison of formoterol and terbutaline for as-needed treatment of asthma: a randomised trial.
    Tattersfield AE, Löfdahl CG, Postma DS, Eivindson A, Schreurs AG, Rasidakis A, Ekström T.
    Lancet; 2001 Jan 27; 357(9252):257-61. PubMed ID: 11214127
    [Abstract] [Full Text] [Related]

  • 20. Adjustable maintenance dosing with budesonide/formoterol compared with fixed-dose salmeterol/fluticasone in moderate to severe asthma.
    Aalbers R, Backer V, Kava TT, Omenaas ER, Sandström T, Jorup C, Welte T.
    Curr Med Res Opin; 2004 Jan 27; 20(2):225-40. PubMed ID: 15006018
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.